All | Group A | Group B | Group C | p value (among groups) | |
---|---|---|---|---|---|
Pre-HD: MPO pg/mL | |||||
Baseline | 73.3 ± 54.1 | 94 1 ± 93.9 | 73.5 ± 44.6 | 67.5 ± 42.4 | 0.22 |
8th week | 72.0 + 63.1 | 93.7 ± 105.3 | 77.0 ± 76.4 | 63.5 ± 33.2 | 0.21 |
p value | 0.79 | 0.98 | 0.75 | 0.98 | |
Post-HD: MPO pg/mL | |||||
Baseline | 283.5 ± 215.2 | 370.6 ± 293.3 | 229.9 ± 165.8 | 287.2 ± 208.3 | 0.10 |
8th week | 271.8 ± 221.0 | 317.1 ± 222.4 | 195.0 ± 54.9 | 299.1 ± 242.1 | 0.07 |
p value | 0.47 | 0.51 | 0.002 | 0.53 | |
Pre-HD: LN(MPO pg/mL) | |||||
Baseline | 4.11 ± 0.58 | 4.26 ± 0.69 | 4.12 ± 0.61 | 4.06 ± 0.53 | 0.46 |
8th week | 4.07 ± 0.58 | 4.17 ± 0.76 | 4.08 ± 0.67 | 4.03 ± 0.47 | 0.68 |
p value | 0.39 | 0.54 | 0.67 | 0.54 | |
Post-HD: LN(MPO pg/mL) | |||||
Baseline | 5.41 ± 0.70 | 5.66 ± 0.73 | 5.18 ± 0.76 | 5.46 ± 0.64 | 0.06 |
8th week | 5.32 ± 0.77 | 5.55 ± 0.64 | 4.98 ± 0.78 | 5.43 ± 0.74 | 0.01 |
p value | 0.02 | 0.52 | 0.002 | 0.52 |